Ace Aquatec develops welfare-focused aquaculture technology to enhance fish welfare and operational performance.

CSignum develops electromagnetic field signaling technology for reliable data transmission in challenging environments like underwater and underground.

uFraction8 develops microfluidics-based filter systems to improve productivity for bio-manufacturers with energy-efficient and scalable perfusion systems.

Concinnity is a biotech company that uses AI-driven RNA-based systems to enhance the safety of gene therapies.

Biotangents develops on-farm diagnostic technology for dairy cows to quickly detect issues like bovine mastitis, aiming to improve herd health and reduce antibiotic use.

Cytomos is a biotechnology company that develops scalable cell-analysis technology to provide cost-effective solutions for biopharma companies.

Invizius is a biotech company developing H-Guard, a product designed to reduce inflammatory responses in dialysis and ICU patients undergoing continuous renal replacement therapy.

SOLASTA Bio develops peptide-based, nature-inspired bioinsecticides as sustainable alternatives to synthetic chemicals in the insecticide market.

Glox Therapeutics develops precision antibiotics targeting drug-resistant bacteria, with a focus on creating high-potency bacteriocins to selectively target and kill antibiotic-resistant Gram-negative pathogens while preserving the patient's microbiome.

Beta Bugs is an Edinburgh-based insect genetics company that breeds and supplies Black Soldier Fly eggs and larvae as a sustainable alternative protein source for aquaculture, pork, and poultry feed.

Glasgow diagnostics spinout Microplate Dx has closed a £2.5 million seed funding round to develop its point-of-care diagnostic platform, which can confirm the presence of bacteria and rapidly identify effective antibiotics to use and which ones to avoid.